GILongevity

GILongevity is a biotechnology company focused on developing therapeutics that target the intersection of gastrointestinal health and the biology of aging. The company leverages insights into the gut microbiome and intestinal barrier function to create interventions aimed at extending healthy lifespan and treating age-related metabolic and inflammatory diseases. By modulating gut-derived signals and maintaining mucosal integrity, GILongevity seeks to mitigate systemic inflammation and promote metabolic homeostasis. Their approach combines advanced microbiome profiling with targeted small molecule and microbial-based drug discovery.